Kenilin Brand Formulations
The FDA published guidelines in 2004 for a new type of combination drugs (pharmaceutical and botanical). Kenilin is not yet approved but is in the process of running approved studies that permit the first human trials to commence at Rose Medical Center, Denver Colorado and State University of New York (Downstate Medical Center, Brooklyn, NY).
The Name Kenilin
Kenilin is the name of both our medicine and our company, derived from the first names of the original developers of the product, Kenneth Burton MD and Lindsey Berkson MA CNS.
|